Related Experiment Video
Updated: May 9, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Ovarian cancer genome.
1Laboratory of Molecular Oncology, NN Petrov Institute of Oncology, St-Petersburg, Russia.
Ovarian cancer (OC) risk is significant, with mutations in DNA repair genes like BRCA1/2 contributing. Understanding these genetic factors and developing bioinformatics tools are crucial for new OC treatments.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Ovarian cancer (OC) is a common malignancy with a lifetime risk of approximately 1 in 70.
- 15-25% of OC cases are linked to germline mutations in DNA repair genes (e.g., BRCA1, BRCA2).
- Sporadic OC can exhibit 'BRCAness,' characterized by BRCA1 gene inactivation, conferring sensitivity to certain therapies.
Purpose of the Study:
- To highlight the role of DNA repair gene mutations in ovarian cancer.
- To emphasize the need for advanced bioinformatic tools for interpreting complex molecular data in OC.
- To underscore the potential for novel diagnostic markers and treatments through molecular profiling.
Main Methods:
- Review of genetic factors in ovarian cancer etiology.
- Analysis of the concept of 'BRCAness' in sporadic OC.
- Discussion on the challenges and necessity of bioinformatic integration of high-throughput molecular profiling data.
Main Results:
- Germline mutations in DNA repair genes are a significant cause of hereditary OC.
- BRCA1 deficiency, whether inherited or somatic, leads to sensitivity to specific anticancer drugs.
- High-throughput molecular profiling generates vast datasets requiring sophisticated interpretation.
Conclusions:
- Understanding genetic predispositions and molecular profiles is key to advancing OC diagnosis and treatment.
- Bioinformatic tools are essential for integrating complex molecular data to derive meaningful insights.
- Targeted therapies exploiting genetic vulnerabilities, like BRCA1 deficiency, offer promising treatment strategies for ovarian cancer.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell